Table 1.
ACC/AHA and ADA Guidelines on Statin Use in Patients with Diabetes
| Society | Patient Population | Recommendation | Recommendation class or level of evidence |
|---|---|---|---|
| ADA | Patients with diabetes and ASCVD or PCE risk > 20% | Recommend high intensity statin use | Level of evidence: A |
| ADA | Patients with diabetes and without ASCVD aged 40 to 75 years old | Recommend moderate intensity statin | Level of evidence: A |
| ADA | Patients with diabetes and without ASCVD > 75 years old | Recommend moderate intensity statin | Level of evidence: B |
| ACC/AHA | Patients with diabetes and other ASCVD risk factors | Consider high intensity statin | Class IIa |
| ACC/AHA | Patients with diabetes and without ASCVD aged 40 to 75 years old | Recommend moderate intensity statin | Class I |
ACC/AHA, American College of Cardiology/American Heart Association; ADA, American Diabetes Association; ASCVD, atherosclerotic cardiovascular disease; PCE, Pooled Cohort Equation